Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

EU Submission Q4 2017, so don't be surprised if something really, really crazy out of left field happens before that (September/October time-frame). I suspect that Advaxis is extremely confident in their ability to receive approval and BPs closest to them currently (Merck, BMS, etc.) are probably watching very closely. And, who knows, maybe there are other BPs on the sidelines just keeping a pulse on Advaxis.

I think it's relatively quiet these next 2 months, but come September things could get very, very interesting. Although I would prefer a BO post EU approval, I think it makes more sense for a BP to get in front of it, assuming the confidence level of those watching that EU approval will pass, as well as the significance of the platform. Regardless, the pps should appreciate significantly before Thanksgiving, since I believe the submission will probably happen after September, sometime before Thanksgiving.

Expect the unexpected with this company. And a BO in September/October, prior to EU submission, would be totally unexpected.